PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15626738-6	2005	Overexpression of Bcl-x(L) was identified as the critical mediator of drug resistance and recapitulates the PTK inhibitor and daunorubicin-resistant phenotype in FLT3-ITD cells.	Daunorubicin	126-138	BCL2 like 1	Homo sapiens	18-26	
11801602-12	2002	Furthermore, doses of D-e-C(6) ceramide that induce the alternative splicing of both caspase 9 and Bcl-x-sensitized A549 cells to daunorubicin.	Daunorubicin	130-142	BCL2 like 1	Homo sapiens	99-104	
33982799-0	2021	NOXA-mediated degradation of MCL1 and BCL2L1 causes apoptosis of daunorubicin-treated human acute myeloid leukemia cells.	Daunorubicin	65-77	BCL2 like 1	Homo sapiens	38-44	
33982799-3	2021	DNR-induced apoptosis in U937 cells accompanied by downregulation of MCL1 and BCL2L1, upregulation of Phorbol-12-myristate-13-acetate-induced protein 1 (NOXA), and mitochondrial depolarization.	Daunorubicin	0-3	BCL2 like 1	Homo sapiens	78-84	
33982799-8	2021	Restoration of MCL1 or BCL2L1 expression alleviated DNR-induced mitochondrial depolarization and cell death.	Daunorubicin	52-55	BCL2 like 1	Homo sapiens	23-29	
33982799-11	2021	Collectively, these results indicate that the upregulation of NOXA expression through the NOX4-ROS-p38 MAPK-GSK3beta-CREB axis results in the degradation of MCL1 and BCL2L1 in DNR-treated U937 and HL-60 cells.	Daunorubicin	176-179	BCL2 like 1	Homo sapiens	166-172	
30361682-6	2018	Furthermore, combined inhibition of Bcl-2/Bcl-XL and Mcl-1 could revert BMSC-mediated resistance against cytarabine + daunorubicin.	Daunorubicin	118-130	BCL2 like 1	Homo sapiens	42-48